This episode features Orahn Preiss-Bloom, Chief Innovation Officer of OSSIO, discussing the company's revolutionary tech that promotes natural healing in bones. OSSIO is tackling the long-standing issues associated with metal implants in orthopedic surgery, which often lead to complications like hardware removal surgeries, patient pain, and increased healthcare costs. Orahn explains how their OSSIOfiber product, a composite material made of biocompatible mineral fibers, provides the necessary strength for bone fixation while allowing the body to naturally remodel it into bone over time, eliminating the need for future hardware removal. The conversation delves into the challenges of bringing novel medical technologies to market, the importance of focusing on procedure-specific solutions, and the intricacies of building a successful go-to-market strategy in the orthopedic space. Orahn shines a light on how the market is shifting towards procedure ownership, where companies provide comprehensive solutions rather than just individual tools. Packed with insights into navigating the regulatory landscape, building a strong commercial team, and optimizing distribution strategies, this conversation will definitely leave you informed and inspired.